Acanthamoeba keratitis is a rare but blinding parasitic eye disease. Experts share how to avoid it and treat it.
VIVIAN Nosovitsky lost vision in her right eye after it was “eaten away” by a parasite she caught “on the bus”. The ...
Vivian Nosovitsky told Newsweek the rare eye infection came from bacteria getting into her contact lenses, causing the ...
Check out our weekly list of new fundraisers from Lend A Hand Up, a nonprofit crowdfunding site supporting families in Cass, ...
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 monthsNotable ...
Signs and symptoms of ocular surface disease could be significantly reduced within 4 days after treatment with shelf-stable ...
The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis (AK), an ultra-rare parasitic infection that can lead to blindness. Akantior ...
Bengaluru-based clinical-stage regenerative medicine player Pandorum Technologies has entered into a strategic collaboration ...
OSN Cornea/External Disease Board Member Eric D. Donnenfeld, MD, and a panel of experts examined a series of unusual ...
Shares of Krystal Biotech soar 57% in a year as strong Vyjuvek uptake and steady pipeline progress continue to push the stock ...
Kolkata: Scientists from the Bose Institute, Kolkata, and the LV Prasad Eye Institute, Hyderabad, identified a novel ...
Pandorum Technologies and Nucelion Therapeutics announce collaboration to manufacture exosome-based tissue regenerative therapy for ocular diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback